Medicaid Coverage for Obesity Medications: Utilization and Net-of-Rebate Spending
Coady Wing,
Wei-Lun Lo,
Maddie Potter,
Tarik Yuce,
Alberto Ortega,
John Cawley,
Thuy D. Nguyen and
Kosali Simon
No 34949, NBER Working Papers from National Bureau of Economic Research, Inc
Abstract:
We document state variation in Medicaid coverage for obesity-indicated GLP-1 medications over time, and use a stacked difference-in-differences design to estimate the effects of coverage on utilization and net-of-rebate spending. Nine quarters out, coverage increases prescriptions for obesity-indicated GLP-1 medications by 0.82 per 100 enrollee-months (SE = 0.10). Coverage had no effect on GLP-1 prescribing for diabetes or cardiovascular indications, suggesting that off-label prescribing of diabetes formulations for obesity is not very common in the Medicaid program. The expansions do not appear to affect consumer spending at major online GLP-1 compounding firms, which suggests that the utilization response in our main analysis reflects new utilization rather than crowd-out. We find that coverage increases net-of-rebate Medicaid spending by $751.6 per 100 enrollee-months (SE = $92.0), compared to $986.9 in gross reimbursements—manufacturer rebates reduce the state’s net spending by approximately 24 percent. Across the 17 states that ever covered obesity-indicated GLP-1 medications by mid 2025, coverage increased Medicaid net spending by around $2.68 billion per year. Extending Medicaid coverage in the remaining states would generate a further $3.63 billion in annual net spending.
JEL-codes: I11 I13 I18 (search for similar items in EconPapers)
Date: 2026-03
New Economics Papers: this item is included in nep-edu and nep-hea
Note: AG CH EH PE
References: Add references at CitEc
Citations:
Downloads: (external link)
http://www.nber.org/papers/w34949.pdf (application/pdf)
Access to the full text is generally limited to series subscribers, however if the top level domain of the client browser is in a developing country or transition economy free access is provided. More information about subscriptions and free access is available at http://www.nber.org/wwphelp.html. Free access is also available to older working papers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberwo:34949
Ordering information: This working paper can be ordered from
http://www.nber.org/papers/w34949
The price is Paper copy available by mail.
Access Statistics for this paper
More papers in NBER Working Papers from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().